High Court Won't Review $5B Vioxx Deal
The U.S. Supreme Court declined Tuesday to hear a challenge to Merck & Co. Inc.'s $4.85 billion resolution of the multidistrict litigation over painkiller Vioxx brought by plaintiffs who claimed the...To view the full article, register now.
Already a subscriber? Click here to view full article